Hemoperfusion in a newborn with early neonatal sepsis (clinical case)

• Anastasiya I. Makulova
• Anna O. Тoporkova
• Uliya S. Kozlova
• Inessa V. Kuznetsova
• Nataliya V. Kholodnova
• Ludmila M. Makarova
• Dmitriy P. Zhurochko
• Ivan I. Afukov

Abstract

This article presents the first sucsessful experience in our country in treating the newborn with sepsis, presumably caused by Escherichia coli, using Efferon LPS NEO pediatric hemoperfusion device.

Keywords:hemosorption; hemoperfusion; newborn; neonate; sepsis; Escherichia coli; renal replacement therapy; dialysis

References

1. Korang S.K., Safi S., Nava C., Gordon A., Gupta M., Greisen G., et al. Antibiotic regimens for early-onset neonatal sepsis. Cochrane Database Syst Rev. 2021; 5 (5): CD 013837. DOI: https://doi.org/10.1002/14651858.CD013837.pub2 PMID: 33998666; PMCID: PMC 8127574.

2. Vatne A., Klingenberg C., Rettedal S., Oymar K. Early-onset sepsis in neonates – a population-based study in south-west Norway from 1996 to 2018. Front Pediatr. 2021; 9: 634798. DOI: https://doi.org/10.3389/fped.2021.634798 PMID: 33816402; PMCID: PMC 8010672.

3. Poggi C., Dani C. New antimicrobials for the treatment of neonatal sepsis caused by multi-drug-resistant bacteria: a systematic review. Antibiotics. 2023; 12 (6): 956. DOI: https://doi.org/10.3390/antibiotics12060956

4. Polcwiartek L.B., Smith P.B., Benjamin D.K., Zimmerman K., Love A., Tiu L., et al. Early-onset sepsis in term infants admitted to neonatal intensive care units (2011–2016). J Perinatol. 2021; 41 (1): 157–63. DOI: https://doi.org/10.1038/s41372-020-00860-3 PMID: 33070153; PMCID: PMC 7568457.

5. Stoll B.J., Puopolo K.M., Hansen N.I., Sánchez P.J., Bell E.F., Carlo W.A., et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early-onset neonatal sepsis 2015 to 2017, the rise of Escherichia coli, and the need for novel prevention strategies. JAMA Pediatr. 2020; 174 (7): e200593. DOI: https://doi.org/10.1001/jamapediatrics.2020.0593 PMID: 32364598; PMCID: PMC 7199167.

6. Lai J., Zhu Y., Tang L., Lin X. Epidemiology and antimicrobial susceptibility of invasive Escherichia coli infection in neonates from 2012 to 2019 in Xiamen, China. BMC Infect Dis. 2021; 21 (1): 295. DOI: https://doi.org/10.1186/s12879-021-05981-4 PMID: 33757434; PMCID: PMC 7988952.

7. Greenfield K.G., Badovinac V.P., Griffith T.S., Knoop K.A. Sepsis, cytokine storms, and immunopathology: the divide between neonates and adults. Immunohorizons. 2021; 5 (6): 512–22. DOI: https://doi.org/10.4049/immunohorizons.2000104 PMID: 34183380; PMCID: PMC 8686527.

8. Eremenko A.A., Marchenko T.V., Nikoda V.V., Zokoev A.K., Skripalenko D.A. Endotoxin and cytokines removal with adsorption device in a child with sepsis after transplantectomy (case report). Obshchaya reanimatologiya [General Reanimatology]. 2023; 19 (6): 48–53. DOI: https://doi.org/10.15360/1813-9779-2023-6-48-53 (in Russian)

9. Aleksandrovich Yu.S., Serednyakov K.V., Pshenisnov K.V. Extracorporeal hemocorrection in complex therapy of septic shock in children. Anesteziologiya i reanimatologiya [Anesthesiology and Reanimatology]. 2021; (4): 110–7. (in Russian)

10. Ronco C., Bellomo R. Hemoperfusion: technical aspects and state of the art. Crit Care. 2022; 26: 135. DOI: https://doi.org/10.1186/s13054-022-04009-w

11. Fleischmann C., Reichert F., Cassini A., Horner R., Harder T., Markwart R., et al. Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis. Arch Dis Child. 2021; 106 (8): 745–52. DOI: https://doi.org/10.1136/archdischild-2020-320217 PMID: 33483376; PMCID: PMC 8311109.

12. Sturrock S., Sadoo S., Nanyunja C., Le Doare K. Improving the treatment of neonatal sepsis in resource-limited settings: gaps and recommendations. Res Rep Trop Med. 2023; 14: 121–34. DOI: https://doi.org/10.2147/RRTM.S410785 PMID: 38116466; PMCID: PMC 10728307.

13. Meshram R.M., Gajimwar V.S., Bhongade S.D. Predictors of mortality in outborns with neonatal sepsis: a prospective observational study. Niger Postgrad Med J. 2019; 26 (4): 216–22. DOI: https://doi.org/10.4103/npmj.npmj_91_19 PMID: 31621661.

14. Miselli F., Cuoghi Costantini R., Creti R., Sforza F., Fanaro S., Ciccia M., et al. Escherichia coli is overtaking group B Streptococcus in early-onset neonatal sepsis. Microorganisms. 2022; 10 (10): 1878. DOI: https://doi.org/10.3390/microorganisms10101878 PMID: 36296155; PMCID: PMC 9607315.

15. Cai C., Qiu G., Hong W., Shen Y., Gong X. Clinical effect and safety of continuous renal replacement therapy in the treatment of neonatal sepsis-related acute kidney injury. BMC Nephrol. 2020; 21 (1): 286. DOI: https://doi.org/10.1186/s12882-020-01945-z PMID: 32682407; PMCID: PMC 7368639.

16. Garzotto F., Vidal E., Ricci Z., Paglialonga F., Giordano M., Laforgia N., et al. Continuous kidney replacement therapy in critically ill neonates and infants: a retrospective analysis of clinical results with a dedicated device. Pediatr Nephrol. 2020; 35 (9): 1699–705. DOI: https://doi.org/10.1007/s00467-020-04562-y PMID: 32440948.

17. Xu J., Chu X., Zhang W., Sun Y., Qiu G., Cai C., et al. Analysis of risk factors for death in 59 cases of critically ill neonates receiving continuous renal replacement therapy: a two-centered retrospective study. Eur J Pediatr. 2023; 182 (1): 353–61. DOI: https://doi.org/10.1007/s00431-022-04693-4 PMID: 36369399.

18. Rey S., Kulabukhov V.M., Popov A., Nikitina O., Berdnikov G., Magomedov M., et al. Hemoperfusion using the LPS-selective mesoporous polymeric adsorbent in septic shock: a multicenter randomized clinical trial. Shock. 2023; 59 (6): 846–54. DOI: https://doi.org/10.1097/SHK.0000000000002121

19. Ricci Z., Romagnoli S., Reis T., Bellomo R., Ronco C. Hemoperfusion in the intensive care unit. Intensive Care Med. 2022; 48 (10): 1397–408. DOI: https://doi.org/10.1007/s00134-022-06810-1 PMID: 35984473; PMCID: PMC 9389493.

20. Ronco C., Chawla L., Husain-Syed F., Kellum J.A. Rationale for sequential extracorporeal therapy (SET) in sepsis. Crit Care. 2023; 27 (1): 50. DOI: https://doi.org/10.1186/s13054-023-04310-2 PMID: 36750878; PMCID: PMC 9904264.

21. Bottari G., Guzzo I., Marano M., Stoppa F., Ravà L., Di Nardo M., et al. Hemoperfusion with Cytosorb in pediatric patients with septic shock: a retrospective observational study. Int J Artif Organs. 2020; 43 (9): 587–93. DOI: https://doi.org/10.1177/0391398820902469 PMID: 32003289.

22. Saetang P., Samransamruajkit R., Singjam K., Deekajorndech T. Polymyxin B hemoperfusion in pediatric septic shock: single-center observational case series. Pediatr Crit Care Med. 2022; 23 (8): e386–91. DOI: https://doi.org/10.1097/PCC.0000000000002969 PMID: 35687100; PMCID: PMC 9345520.

23. Sazonov V., Abylkassov R., Tobylbayeva Z., Saparov A., Mironova O., Poddighe D. Case series: efficacy and safety of hemoadsorption with HA-330 adsorber in septic pediatric patients with cancer. Front Pediatr. 2021; 9: 672260. DOI: https://doi.org/10.3389/fped.2021.672260 PMID: 34178889; PMCID: PMC 8225958.

24. Nishizaki N., Nakagawa M., Hara S., Oda H., Kantake M., Obinata K., et al. Effect of PMX-DHP for sepsis due to ESBL-producing E. coli in an extremely low-birthweight infant. Pediatr Int. 2016; 58 (5): 411–4. DOI: https://doi.org/10.1111/ped.12825 PMID: 26710929.

25. Nishizaki N., Shima T., Watanabe A., Obinata K., Shimizu T. Unsatisfactory short-term neurodevelopmental outcomes of preterm infants who received polymyxin B-immobilized fiber column-direct hemoperfusion for septic shock. Tohoku J Exp Med. 2021; 253 (4): 275–81. DOI: https://doi.org/10.1620/tjem.253.275 PMID: 33896891.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)